LIF Antikörper (AA 23-202)
Kurzübersicht für LIF Antikörper (AA 23-202) (ABIN7158225)
Target
Alle LIF Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 23-202
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Antigen Affinity Purified
-
Immunogen
- Recombinant Human Leukemia inhibitory factor protein (23-202AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- LIF (Leukemia Inhibitory Factor (LIF))
-
Andere Bezeichnung
- LIF
-
Hintergrund
-
Background: LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes.
Aliases: CDF antibody, Cholinergic Differentiation Factor antibody, D factor antibody, DIA antibody, Differentiation inducing factor antibody, differentiation inhibitory activity antibody, Differentiation stimulating factor antibody, Differentiation-stimulating factor antibody, Emfilermin antibody, Hepatocyte stimulating factor III antibody, HILDA antibody, Human interleukin in DA cells antibody, Leukemia inhibitory factor antibody, LIF antibody, LIF_HUMAN antibody, Melanoma derived LPL inhibitor antibody, Melanoma-derived LPL inhibitor antibody, MLPLI antibody
-
UniProt
- P15018
-
Pathways
- JAK-STAT Signalweg, Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, Stem Cell Maintenance, Growth Factor Binding
Target
-